Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells Jul 7, 2020 | Head & Neck
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations May 20, 2020 | Non-Small Cell Lung Cancer, Triple Negative Breast Cancer
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist. Apr 16, 2020 | Merkel Cell Carcinoma, Non-Small Cell Lung Cancer
Overcoming hypoxia-induced functional suppression of NK cells Apr 8, 2020 | Non-Small Cell Lung Cancer, Triple Negative Breast Cancer
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma Nov 26, 2019 | Solid Tumors
